These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6998708)

  • 1. Time course of blood pressure, pulse rate, plasma renin and metoprolol during treatment of hypertensive patients.
    Haglund K; Collste P
    Eur J Clin Pharmacol; 1980 May; 17(5):321-8. PubMed ID: 6998708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metoprolol on blood pressure and plasma renin activity in thiazide-resistant hypertensive patients.
    Velasquez MT; Han Wan S; Maronde RF
    Clin Pharmacol Ther; 1979 Nov; 26(5):555-61. PubMed ID: 498696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels and effects of metoprolol after single and multiple oral doses.
    Collste P; Haglund K; von Bahr C
    Clin Pharmacol Ther; 1980 Apr; 27(4):441-9. PubMed ID: 6987028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily metoprolol in primary hypertension.
    Karlberg BE; Nilsson O; Tolagen K; Nitelius E; Waern U
    Clin Pharmacol Ther; 1979 Apr; 25(4):399-407. PubMed ID: 371902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of penbutolol and metoprolol on blood pressure, plasma catecholamines and renin activity in hypertensive patients.
    Hansson BG; Dymling JF; Manhem P; Hökfelt B
    Eur Heart J; 1983 Jul; 4 Suppl D():57-60. PubMed ID: 6352273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.
    Hansson BG; Dymling JF; Manhem P; Hökfelt B
    Eur J Clin Pharmacol; 1977 Apr; 11(4):247-54. PubMed ID: 324772
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels and effect on heart rate and blood pressure of metoprolol after acute oral administration in 12 geriatric patients.
    Lundborg P; Steen B
    Acta Med Scand; 1976; 200(5):397-402. PubMed ID: 983811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II blockade during combined thiazide-beta-adrenoreceptor-blocker treatment.
    Ibsen H; Leth A; McNair A; Giese J
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():123s-125s. PubMed ID: 396064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of felodipine and metoprolol on blood pressure, plasma renin, angiotensin II, aldosterone and catecholamines in hypertensive patients.
    Lijnen P; Fagard R; Staessen J; Moerman E; De Schaepdryver A; Amery A
    Drugs; 1987; 34 Suppl 3():170-5. PubMed ID: 3327678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.
    Hansson BG; Dymling JF; Hedeland H; Hulthén UL
    Eur J Clin Pharmacol; 1977 Apr; 11(4):239-45. PubMed ID: 324771
    [No Abstract]   [Full Text] [Related]  

  • 13. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD; Hesse CJ
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
    Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
    N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotalol and metoprolol comparison of their anti-hypertensive effect.
    Andersson O; Berglund G; Descamps R; Thomis J
    Eur J Clin Pharmacol; 1981; 21(2):87-92. PubMed ID: 7341284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension.
    von Bahr C; Collste P; Frisk-Holmberg M; Haglund K; Jorfelt L; Orme M; Ostman J; Sjoqvist F
    Clin Pharmacol Ther; 1976 Aug; 20(2):130-7. PubMed ID: 7373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences with metoprolol Durules, a slow-release formulation in hypertension.
    Tuomilehto J; Nissinen A
    J Int Med Res; 1980; 8(1):44-9. PubMed ID: 7358203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metoprolol in hypertension: an open evaluation.
    Assaykeen TA; Michell G
    Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exercise in hypertension controlled with metoprolol or methyldopa.
    Stoker JB; Sreeharan N; Linden RJ; Barbour MP; Lorimer AR; Hillis WS; Lawrie TD
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():391s-392s. PubMed ID: 540459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.